2014 Ebola outbreak in West Africa

2014 Ebola outbreak in West Africa
Name	2014 West Africa Ebola epidemic
Caption	Electron micrograph of Ebola virus
Disease	Ebola virus disease
Virus	Zaire ebolavirus
First case	Guinea (December 2013 reported March 2014)
Location	Guinea, Liberia, Sierra Leone, Nigeria, Mali, Senegal, United States, Spain
Dates	December 2013 – June 2016 (major outbreak 2014–2015)
Confirmed cases	~28,616
Deaths	~11,310

2014 Ebola outbreak in West Africa was the largest and most complex outbreak of Ebola virus disease since the virus's discovery, primarily affecting Guinea, Liberia, and Sierra Leone. The epidemic overwhelmed national capacities and provoked multi‑national responses from World Health Organization, Médecins Sans Frontières, Centers for Disease Control and Prevention, and regional bodies such as the African Union. It prompted emergency deployments from countries including the United States, United Kingdom, France, and China and catalyzed research at institutions like National Institutes of Health and Pasteur Institute.

Background

The index cluster emerged in southeastern Guéckédou and Meliandou in Nzérékoré Region of Guinea, near borders with Liberia and Sierra Leone, following suspected zoonotic spillover from a reservoir host associated with Fruit bat ecology studied in Makounta and other West African forest sites. Earlier Ebola outbreaks had occurred in Zaire (1976) linked to Yambuku and in Reston, Virginia (1989) involving Ebolavirus Reston, with virology advanced at laboratories including Centers for Disease Control and Prevention and Ivanovsky Institute. The causative agent was identified as Zaire ebolavirus and phylogenetic studies referenced sequences deposited by teams from University of Oxford, Scripps Research Institute, and Kenya Medical Research Institute.

Timeline

Initial cases in December 2013 prompted local clinic reports in early 2014, with formal international alerts in March 2014 by World Health Organization and investigative missions including Médecins Sans Frontières teams. The outbreak escalated through spring and summer 2014, with major transmission in Monrovia, Freetown, and Conakry and exported cases to Lagos, Abidjan, Madrid, and Dallas. Notable events included diagnosis of patients such as Thomas Eric Duncan in Dallas County leading to hospital transmission at Texas Health Presbyterian Hospital Dallas, and a secondary transmission in Madrid linked to healthcare worker infections at Hospital Carlos III. Peak incidence prompted United Nations Security Council briefings and establishment of the United Nations Mission for Ebola Emergency Response (UNMEER). By late 2014 and 2015, case counts declined after sustained interventions, and WHO declared the end of major transmission in 2016 while sporadic flare-ups occurred.

Epidemiology and transmission

Transmission occurred via direct contact with blood, secretions, organs, or other bodily fluids of symptomatic patients and contaminated fomites, with heightened risk during traditional funeral rites in Poro and Secret societies regions and at healthcare facilities lacking sufficient personal protective equipment. Superspreading events in crowded urban settings such as West Point, Monrovia and slums of Freetown amplified spread, while nosocomial transmission affected staff at institutions including Connaught Hospital and John F. Kennedy Medical Center (Monrovia). Age, pregnancy, and comorbidities influenced case fatality rates analyzed by teams from London School of Hygiene & Tropical Medicine, Imperial College London, and Harvard School of Public Health. Genomic epidemiology by groups at Broad Institute and Wellcome Trust Sanger Institute traced multiple transmission chains and cross‑border movement among Forests Region communities.

Response and containment efforts

National responses involved border screening at airports like Lungi International Airport and deployment of emergency medical units from Cuba, Norway, Germany, and Kenya. International coordination included WHO emergency committees, logistical support from United Nations Mission in Liberia assets, and clinical trials coordinated by National Institutes of Health and GlaxoSmithKline testing candidate vaccines (rVSV‑ZEBOV) and therapeutics including ZMapp developed by Mapp Biopharmaceutical and experimental antiviral regimens evaluated at Johns Hopkins University and Duke University. Humanitarian agencies such as International Federation of Red Cross and Red Crescent Societies, Oxfam, and Save the Children provided community engagement, while supply chains involved World Food Programme and NATO logistical support. Challenges included limited laboratory capacity prior to investments from Public Health England and mobile labs from Institut Pasteur, and sociocultural resistance addressed via partnerships with local chiefs, Sierra Leone Armed Forces liaison officers, and faith leaders.

Impact and consequences

The epidemic caused profound mortality and morbidity, collapsing routine services at facilities like Connaught Hospital and disrupting vaccination campaigns for measles and maternal health in Guinea, Liberia, and Sierra Leone; economic analyses by World Bank and International Monetary Fund estimated substantial GDP contraction and setbacks in United Nations Development Programme human development indicators. Social consequences included stigma affecting survivors and healthcare workers, trials of justice and reconciliation in post‑epidemic communities, and investment surges in global health security frameworks like the Global Health Security Agenda, Emergency Use Authorization pathways, and reforms at WHO after Independent Panel reviews. The crisis accelerated development of novel vaccines by Merck and strengthened laboratory networks such as Africa Centres for Disease Control and Prevention.

Investigations and origin studies

Field epidemiology teams from Centers for Disease Control and Prevention, World Health Organization, Pasteur Institute, and academic collaborators including University of Cambridge and London School of Hygiene & Tropical Medicine conducted case investigations, ecological surveys, and genomic sequencing to infer a single zoonotic spillover event in late 2013 followed by sustained human‑to‑human transmission. Wildlife surveillance implicated fruit bat species like Hypsignathus monstrosus and Epomops franqueti as plausible reservoirs, with serological and PCR studies published by groups at University of Oxford and Kenya Medical Research Institute. Controversies over burial practices, cross‑border mobility, and urbanization were examined in multidisciplinary studies involving Columbia University and Yale School of Public Health, informing policy on outbreak prevention and One Health initiatives championed by Food and Agriculture Organization and World Organisation for Animal Health.

Category:Ebola virus disease outbreaks